Oruka Therapeutics, Inc. (ORKA) — Defensive Interval Ratio
Oruka Therapeutics, Inc. (ORKA) has a Defensive Interval Ratio of 4490 days as of September 2025. Defensive assets of $257.90 Million (cash $-, short-term investments $257.90 Million, receivables $-) cover 4490 days of daily cash needs of $57.44K/day. Check Oruka Therapeutics, Inc. tangible equity quality to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Oruka Therapeutics, Inc. Defensive Interval Ratio (2005–2024)
This chart shows how Oruka Therapeutics, Inc.'s Defensive Interval Ratio has evolved across 6 annual periods from 2005 to 2024. As of September 2025, the ratio stands at 4490 days, meaning defensive assets of $257.90 Million can fund 4490 days of operations without new revenue. Also explore Oruka Therapeutics, Inc. (ORKA) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Oruka Therapeutics, Inc. (2005–2024)
The table below presents the year-by-year Defensive Interval Ratio for Oruka Therapeutics, Inc. from 2005 to 2024, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see ORKA stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 8789 days | $314.07 Million | $35.73K/day | $- | $314.07 Million | ▲ +8251 days |
| 2017 | 538 days | $3.05 Million | $5.67K/day | $- | $3.05 Million | ▼ -1559 days |
| 2016 | 2096 days | $13.76 Million | $6.56K/day | $- | $13.76 Million | ▲ +770 days |
| 2007 | 1326 days | $66.09 Million | $49.83K/day | $- | $65.51 Million | ▲ +483 days |
| 2006 | 844 days | $101.35 Million | $120.11K/day | $- | $92.79 Million | ▲ +503 days |
| 2005 | 341 days | $33.78 Million | $99.13K/day | $- | $32.57 Million | — |